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Mucus colonization is an essential early step toward establishing successful infection and
disease by mucosal pathogens. There is an emerging literature implicating speciﬁc mucin
sub-types and mucin modiﬁcations in protecting the host from Campylobacter jejuni infec-
tion. However, mucosal pathogens have evolved sophisticated mechanisms to breach the
mucus layer and C. jejuni in particular appears to harbor speciﬁc adaptations to better
colonize intestinal mucus. For example, components of mucus are chemotactic for C.
jejuni and the rheological properties of mucus promote motility of the organism. Further-
more, recent studies demonstrate that mucins modulate the pathogenicity of C. jejuni in
a species-speciﬁc manner and likely help determine whether these bacteria become path-
ogenic (as in humans), or adopt a commensal mode of existence (as in chickens and other
animals). This review focuses on recent advances in understanding the complex interplay
between C. jejuni and components of the mucus layer.
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INTRODUCTION
MUCUS COMPOSITION
The visco-elastic mucus gel layer consists of an outer loose layer
containing gutmicrobiota andan innermore compact layer devoid
of any bacteria (Johansson et al., 2008). The thickness of themucus
layer ranges from 10μm in the eye to 700μm in the intestine
(Linden et al., 2008b). Mucin glycoproteins are the main com-
ponents of mucus while others include; cathelicidins, defensins,
lysozyme, protegrins, collectins, antibodies, nitric oxide, and his-
tatins. Collectively these constituents of mucus form a physical
barrier, participate in bacterial clearance, and display antimicro-
bial activity (Linden et al., 2008b; McGuckin et al., 2011). Other
protective bioactive molecules in mucus include trefoil factors
involved in the repair and restitution of the epithelial mucosa
(Taupin and Podolsky, 2003), and resistin-likemolecule β (Relmβ)
which contribute to the barrier properties of mucus by enhancing
mucin gene expression and preventing bacteria from breaching
the mucus layer (Hogan et al., 2006; Krimi et al., 2008). In gen-
eral, mucus protects underlying epithelial cells from chemical,
microbial, enzymatic, and mechanical damage.
Themain component of mucus,mucin glycoproteins, are heav-
ily o-glycosylated in large peptide domains harboring repeats of
the amino acids serine and threonine. These areas are known
as variable number tandem repeat (VNTR) regions and vary in
length both between individuals and different mucin types, lead-
ing to VNTR polymorphisms. Carbohydrates constitute approxi-
mately 70%of themass of mucin glycoproteins, conferringmucins
with water holding capacity, rigidity, protease resistance, and a
high charge density (Klein et al., 1993; Moncada et al., 2003). Up
to 16 human mucins have been described, falling into three sub-
families: secreted mucins (MUC7), cell surface mucins (MUC1,
MUC4,MUC3A/B,MUC12,MUC13,MUC15,MUC16,MUC 17,
MUC20), and gel-forming mucins (MUC2, MUC5AC, MUC5B,
MUC6, and MUC19). A cluster of four genes on chromosome
11 encode gel-forming mucins, which are the main mucin sub-
family in mucus and confer its visco-elastic properties. Cysteine
residues at the N- and C-termini of gel-forming mucins form
intermolecular and intramolecular disulﬁde bonds, leading to
homo-oligomerization of mucins in regions known as von Wille-
brand factor-like or D domains (Moncada et al., 2003; Linden
et al., 2008b). In the gastrointestinal tract, mucin types are differ-
entially expressed. Mucin sub-types in the colon include MUC2,
MUC1, MUC3A/B, MUC4, MUC12, MUC13, MUC15, MUC17,
and MUC20. The stomach contains MUC5AC, MUC6, MUC1,
MUC4, MUC12, MUC13, and MUC17, while small intestinal
mucins include MUC2, MUC3A/B, MUC12, MUC13, MUC15,
and MUC17 (Moran et al., 2011).
MUCUS AND ENTERIC BACTERIAL PATHOGENS
Enteric pathogens have to colonize and circumvent the mucus
layer prior to causing disease. To establish infection, these bacte-
ria have to bypass both physical and immunological barriers in
the gastrointestinal tract. The visco-elastic mucus gel layer pro-
tects underlying epithelial cells by trapping pathogens in the loose
mucus and clearing them both during gut movements and mucus
turnover. In addition, mucin glycoproteins bind and retard bac-
teria in mucus, preventing them from accessing epithelial cells.
Furthermore, antimicrobial peptides present in mucus and gut
microﬂora are directly antagonistic to pathogens. Intestinalmicro-
biota also competitively exclude gut pathogens by occupying
mucin receptors, hence preventing pathogen access to the mucosa
(reviewed in Linden et al., 2008b).
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Enteric pathogens typically breach the mucus layer by employ-
ing mucus degradative enzymes. Mucinases, sialidases, N -acetyl
neuraminate lyases, glycosulfatases, and sialate o-acetylesterases
are some of the mucinolytic enzymes employed by gut pathogens
(Corﬁeld et al., 1992, 1993; Haider et al., 1993; Homer et al.,
1994). For exampleVibrio cholerae expressesHapAwhich has both
mucinolytic and cytotoxic activity (Silva et al., 2003). In addition,
chemotaxis and ﬂagellar motility facilitate colonization and pene-
tration of themucus barrier by enteric pathogens (discussed below
for Campylobacter jejuni).
In response to the presence of gut microbes, mucin synthesis
and glycosylation are regulated. Adherence by probiotic bacte-
ria and products from some bacteria increase the synthesis of
mucins from epithelial cells (Smirnova et al., 2003). For exam-
ple, colonic Muc1 expression is upregulated in both mouse and
human intestinal bacterial infections (Linden et al., 2008a). Fur-
thermore, mucin glycosylation changes have been documented
following Helicobacter pylori infection (reviewed in Moran et al.,
2011) and H. pylori lipopolysaccharide (LPS) inhibits mucin syn-
thesis in gastric epithelial cells (Slomiany and Slomiany, 2006). H.
pylori and the stomach gel-forming mucin MUC5AC have been
shown to colocalize, and these bacteria bind the dimeric form of
the human recombinant trefoil factor 1 (TFF1; Van den Brink
et al., 2000; Clyne et al., 2004). Recently, it has been shown that
H. pylori binds TFF1 by means of its rough form LPS in a pH
dependent manner (Reeves et al., 2008). The mechanism of bac-
terial LPS binding to TFF1 is not known. However, TFF1 harbors
a hydrophobic patch of solvent-exposed residues on its surface
which may act as a possible carbohydrate binding domain (Reeves
et al., 2008). In addition, a pH of between 5 and 6 was found to
be optimal for the interaction between TFF1 and H. pylori. This
pH range is typical of that found in the mucosal niche occupied
by H. pylori in vivo supporting the possibility that H. pylori bind-
ing to TFF1 may promote bacterial colonization in the stomach
(Schreiber et al., 2004; Reeves et al., 2008).
From the above it is clear that while on the one hand com-
ponents of mucus inﬂuence bacterial colonization and virulence
properties, on the other, the presence of bacteria has a marked
effect on mucin expression. Therefore, while the mucus layer
and its constituents form part of the innate defense against
pathogens, mucosal organisms have evolved remarkable strate-
gies to circumvent (or even subvert for their own advantage) this
barrier.
THE INTERACTION OF C. JEJUNI WITHMUCUS ANDMUCINS
MUCUS AND MUCINS AS A BARRIER IN C. JEJUNI INFECTION
Much of our understanding of how intestinal mucins protect the
mucosa from infection with C. jejuni has evolved only recently,
led by groundbreaking work from McGuckin and colleagues at
the University of Queensland (McAuley et al., 2007; Linden et al.,
2008a,b; Dawson et al., 2009). The cell surface mucin, Muc1, was
found to be upregulated following infection with both the nat-
ural mouse pathogen Citrobacter rodentium and with C. jejuni
(McAuley et al., 2007; Linden et al., 2008a). Muc1 negative mice
were shown to have a marked increase in translocation of C. jejuni
to systemic organs. In addition Muc1 is upregulated in human
colonic biopsies following naturally occurring C. jejuni infection
(Linden et al., 2008a). A not dissimilar role for mucin sulfation
in the protection of mice from C. jejuni systemic infection (a
marker of intestinal barrier function) subsequently was demon-
strated using amouseNas1 knockoutmodel (Dawson et al., 2009).
Interestingly,whileMuc1 also has a role in protectingmice fromH.
pylori infection, it does not help protect mice from the pathologic
effects of H. felis infection (Every et al., 2008). From these experi-
ments, it is obvious that the mucus barrier has evolved a complex
array of protective mechanisms against infection and these appear
not to be simply generic antibacterial barriers. Nonetheless, it will
be important to attempt to document the role of thesemucus char-
acteristics inCampylobacter models that approximatemore closely
those of human infection, a problem that continues to bedevil the
wider ﬁeld of Campylobacter pathogenesis.
ADAPTATIONS OF C. JEJUNI TO LIFE IN THE MUCUS LAYER
Ultimately, C. jejuni is very successful in overcoming the intricate
barrier structures posed bymucus andmucins in order to establish
enteric infection, at least in the human intestinal tract. While the
exact details of how C. jejuni establishes infection remain elusive,
the complex interplay between bacterium and host mucosal sur-
face has been the subject of intensive research in recent years and
an understanding is beginning to emerge of the role of mucus in
that relationship.
Motility/chemotaxis
Flagellar motility and chemotaxis toward components of mucus
are thought to be crucial in the life cycle of C. jejuni, both as a
commensal and as a pathogen. Virulence in the ferret model, host
colonization, adhesion, and invasion all require ﬂagellar motility
(Young et al., 2007). Chemotaxis receptors together with other
elements of the C. jejuni chemotaxis and motility machinery are
known to be required for colonization in a chick model of infec-
tion (Hendrixson and DiRita, 2004). Likewise, ﬂagellar genes and
regulators of ﬂagellar biosynthesis such as FlgR, σ28, and σ54 are
all required for chick colonization (Hendrixson, 2006). Chemoat-
tractants for C. jejuni include amino acids such as l-glutamate,
l-serine, l-cysteine, l-aspartate, and the sugar fucose (Hugdahl
et al., 1988; Szymanski et al., 1999).
In solutions of increased viscosity comparable to mucus, C.
jejuni is highlymotile,demonstrating peaks ofmotilitywith longer
path lengths (Ferrero and Lee, 1988; Szymanski et al., 1995). The
corkscrew-like shape of these bacteria and the relatively short
O-side chains of its lipooligosaccharide (LOS) are purported to
prevent non-speciﬁc binding of C. jejuni to mucin glycoproteins
(McSweegan and Walker, 1986). This suggests an adaptation of
these bacteria to the environment of mucus, thus conferring C.
jejuni with an ecological advantage while in mucus (Ferrero and
Lee, 1988). Increased motility of C. jejuni in highly viscous solu-
tions correlateswith increased virulence in vitro. Pre-incubation of
C. jejuni inmedia of increased viscosity increases bacterial binding
and internalization into Caco-2 cells (Szymanski et al., 1995).
Reproduction in mucus
Campylobacter jejuni has been shown to reproduce in chicken
mucus (Van Deun et al., 2008). Van Deun et al. showed that C.
jejuni multiplies in PBS supplemented with mucus but not in
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PBS alone or chicken cecal contents. In agreement with these
ﬁndings, we have recently demonstrated C. jejuni replication
in growth medium supplemented with mucus derived from a
mucus-adherent subclone of methotrexate treated HT29 cells,
HT29MTXE12 (E12; Alemka et al., 2010a). We also showed that
C. jejuni reproduced following colonization of E12 cells (with
mucus), compared with HT29 cells that lacked a mucus layer.
Taken together, these studies indicate that C. jejuni grows and
thrives in the mucus milieu, an adaptation that likely helps to
ensure its persistence in the host.
Adhesion/invasion and pathogenicity
Conventional tissue culture has contributed greatly to our under-
standing of how enteric pathogens such as C. jejuni elaborate
disease. For instance, infection studies with intestinal epithelial
cells led to the identiﬁcation of C. jejuni adhesins such as CadF.
CadF, also required for chick colonization (Ziprin et al., 1999),
binds ﬁbronectin located at the basolateral aspects of cells, and
facilitates bacterial internalization (Monteville et al., 2003; Krause-
Gruszczynska et al., 2007). Likewise, JlpA, a lipoprotein on the
surface of C. jejuni, interacts with heat shock protein 90α leading
to the activation of p38mitogen activated protein kinases (MAPK)
and NF-κB, thereby eliciting pro-inﬂammatory responses in Hep-
2 cells (Jin et al., 2003). In addition, both microtubules (Hu and
Kopecko, 1999) and the actin cytoskeleton (Monteville et al., 2003;
Krause-Gruszczynska et al., 2007) are involved in C. jejuni inva-
sion. Furthermore, these bacteria translocate cultured intestinal
epithelial cells by migrating through both the paracellular (Mon-
teville and Konkel, 2002) and transcellular routes (Bras and Ketley,
1999; Hu et al., 2008).
Despite the utility of conventional cell lines, the absence of an
adherent mucus layer on these models is a signiﬁcant weakness.
In order to overcome this, we have attempted to better understand
the role of mucus in infection by characterizing the interaction of
C. jejuni with E12 cells (Behrens et al., 2001; Alemka et al., 2010a).
E12 cells were ﬁrst validated as an appropriate in vitro model of
Campylobacter–host interactions by demonstrating mucus colo-
nization (Figure 1), adhesion, invasion, and translocation to the
basolateral aspects of cells. Compared with parental HT29 cells
that lack a mucus layer, there was enhanced bacterial binding and
internalization into E12 cells (Alemka et al., 2010a). Combined
with previous studies (de Melo and Pechere, 1988; Szymanski
FIGURE 1 | Fluorescence microscopy image of C. jejuni colonization of
E12 mucus. E12 cells were grown for 14 days in transwell inserts and
infected with C. jejuni. The ﬁlter was excised and wrapped between two
pieces of frozen liver and sections probed with DAPI (A) to reveal cell nuclei
and (B) anti-Campylobacter antibodies. Mag: ×400.
et al., 1995; Byrne et al., 2007) these ﬁndings indicate that C. jejuni
not only has evolved mechanisms to breach the protective mucus
barrier layer, but also appears to have subverted the mucus to
enhance pathogenicity. In support of this concept, the presence of
MUC2 (themain intestinal gel-formingmucin) has been shown to
upregulate a number of C. jejuni virulence genes, including those
involved in motility (ﬂaA), adhesion (jlpA), invasion (ciaB), and
toxin formation (cdt ; Tu et al., 2008).
Which component or characteristic of mucus and mucin that
modulates C. jejuni pathogenicity is not known. However, recent
studies have suggested some intriguing possibilities. It has long
been known that C. jejuni does not metabolize glucose due to
the absence of the enzyme phosphofructokinase in its genome
(Parkhill et al., 2000; Guccione et al., 2008) and, because of the
absence of genes involved in sugar metabolism (Parkhill et al.,
2000; Muraoka and Zhang, 2011), it has generally been assumed
that this organism is unable to use any form of carbohydrate as
a substrate. Rather these bacteria use amino acids such as glu-
tamate, asparagine, proline, serine, and aspartate as a source of
carbon (Guccione et al., 2008; Hofreuter et al., 2008).
However, C. jejuni was recently shown to metabolize fucose
(Muraoka and Zhang, 2011; Stahl et al., 2011). In these studies,
growth of C. jejuni was enhanced in media supplemented with
fucose. Several strains of C. jejuni now have been shown to pos-
sess a genomic island that is linked with the ability to take up
and utilize fucose as a source of carbon (Stahl et al., 2011). In
light of the fact that Campylobacter displays chemotaxis to mucin
(which harbors fucosylated glycans), binds to mucin (Sylvester
et al., 1996), and the ﬁnding that these bacteria reproduce in
both human and chicken mucus (Van Deun et al., 2008; Alemka
et al., 2010a), it is tempting to speculate that C. jejuni acquires and
utilizes constituents of mucus to sustain its commensal and path-
ogenicmodes of existence, and that differences in the composition
of mucus across species may contribute to C. jejuni pathogenicity
in humans as opposed to commensalism in other animals (dis-
cussed below). Furthermore, the importance of the interaction of
C. jejuni with fucosylated structures possibly could be exploited as
a novel antimicrobial therapy inC. jejuni infections (Ruiz-Palacios
et al., 2003).
Inﬂuence of gut microbiota in the mucus layer
In the gut,microbiota are known to colonize the outer loosemucus
layer (Johansson et al., 2008). It is thought that microbiota protect
the gut from invading enteric pathogens by competing for nutri-
ents andmucosal binding sites with pathogens, by modulating the
mucosal immune response and also through direct antagonism
(Neish, 2009). Many commensal derived bacteria have been pro-
posed as potential anti infective probiotics. On this basis, we inves-
tigated the effect of probiotic colonizationof themucus of E12 cells
onC. jejuni pathogenicity (Alemka et al., 2010a). Individual probi-
otic strains (Lactobacillus rhamnosus, L. salivarius,Biﬁdobacterium
longum), or cocktails of these probiotics, reduced C. jejuni colo-
nization, invasion, and translocation of mucus-adherent E12 cells
in a strain dependentmanner. Pre-colonization of E12mucuswith
probiotics was required to attenuate C. jejuni virulence, suggest-
ing that probiotics have a potential as prophylactic agents against
C. jejuni infections. The potential use of probiotics to reduce
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Campylobacter numbers in chickens and thereby prevent zoonotic
transmissionmay be a particularly attractive strategy to reduce the
burden of illness in humans.
CHICKEN MUCUS AND CAMPYLOBACTER COMMENSALISM
The consumption of contaminated poultry is the principal mode
of transmission of C. jejuni to humans. Up to 100% of point-of-
sale chicken has been shown to be contaminated with C. jejuni
(Madden et al., 1998; Pearson et al., 2000). Despite heavy colo-
nization (up to 1010 colony forming units per gram of infected
intestine) in chickens,C. jejuni does not cause disease. These bac-
teria avidly colonize the mucus layer of deep cecal crypts, but do
not adhere to or invade chicken intestinal epithelial cells (reviewed
in Young et al., 2007).
WhyC. jejuni is pathogenic in the human population but estab-
lishes a commensal mode of existence in chickens is uncertain. An
obvious difference between humans and chickens is body temper-
ature. The human body temperature is 37˚C while it ranges from
41 to 45˚C in chickens. Campylobacters are therefore adapted to
higher temperatures in chickens but the effect of temperature on
the pathogenicity of C. jejuni is not yet fully understood. The
two-component system RacRS has been implicated as possibly
inﬂuencing the adaptation of C. jejuni to temperature. Mutants in
this regulatory pathway show defects in viability at 42˚C, suggest-
ing that it may contribute to the survival and growth of C. jejuni
at higher temperatures (MacKichan et al., 2004). In addition, dif-
ferences in Campylobacter gene expression have been reported
following growth at 37˚C compared with 42˚C. In one such study
(Stintzi, 2003), at 42˚C, there was an increase in the expression
of chemotaxis and motility genes and an overall 20% general
difference in gene expression compared with 37˚C. Therefore,
body temperaturemay inﬂuence the commensal versus pathogenic
lifestyles of C. jejuni. However, temperature alone is unlikely to
account for the difference in clinical manifestation across species.
We originally hypothesized that species-speciﬁc tissue tropism
might contribute to the differences in clinical outcome of Campy-
lobacter infection in humans and chickens. However, we (Byrne
et al., 2007) and others (Van Deun et al., 2008) subsequently
showed thatC. jejuni both adheres to and invades chicken primary
intestinal cells. These data indicate that Campylobacter com-
mensalism in chickens as opposed to pathogenicity in humans
is not due to lack of the relevant adhesin–receptor interactions
that mediate invasiveness in the chicken intestinal epithelium. In
light of these ﬁndings we investigated the possibility that intestinal
mucus contributes to the inhibitory effect of the chicken intesti-
nal milieu on C. jejuni virulence. We demonstrated that crude
chicken intestinal mucus, markedly attenuates C. jejuni binding
and internalization (Byrne et al., 2007). Consistent with these
ﬁndings, mucus colonization of the human mucus-adherent E12
cell line increased C. jejuni adhesion and invasion of E12 cells
(Alemka et al., 2010a). Subsequently we demonstrated that puri-
ﬁed chicken intestinal mucins, when pre-incubated with C. jejuni,
preferentially attenuate bacterial internalization into HCT-8 cells
(Figure 2). The effect depends on the region of the chicken gut
from where mucins are isolated (Alemka et al., 2010b). In the
same study, attenuation of bacterial invasion by chicken mucins
appeared to have been mediated by mucin glycans, since sodium
metaperiodate treatment of chicken mucins abolished the atten-
uating effect of puriﬁed mucins on bacterial internalization.
Intriguingly, removal of terminal fucose or sialic acid residues
failed to inhibit the effect of chicken mucin on C. jejuni inva-
sion. However, as chickenmucin glycoproteins are heavily sulfated
compared with human mucins (unpublished observations), sul-
fation may have limited the activity of the fucosidase and sialidase
enzymes used in our study (Alemka et al., 2010b). Conversely, it
is possible that sulfation of mucin oligosaccharides may in itself
inﬂuence C. jejuni mucus colonization and pathogenicity across
species. Taken together, these data indicate thatmucus andmucins
modulate C. jejuni virulence properties and may contribute to
the differential clinical manifestations exhibited by C. jejuni in
different hosts (Figure 3).
FIGURE 2 | Purified chicken intestinal mucins attenuate C. jejuni
invasion depending on the region of the chicken gut from which
mucins were isolated (Alemka et al., 2010b, reproduced with
permission). C. jejuni was pre-incubated with mucins prior to infecting
HCT-8 cells. Cae, mucin from the cecum; SI, small intestinal mucins; LI,
large intestinal mucins. *Denotes signiﬁcant difference compared to
control. Cae p<0.05, p<0.005 for SI and LI. Hundred percentage
mucin represents 1mg/ml.
FIGURE 3 | Hypothetical model of how mucus and mucins modulate
the pathogenicity of C. jejuni in a species-specific manner: in mucus
C. jejuni displays chemotaxis and ﬂagellar motility toward components of
mucin. The characteristic spiral shape and the ability of C. jejuni to
replicate in mucus suggests an adaptation of these bacteria to the mucus
milieu. Interaction with human mucin enhances bacterial binding and
internalization into underlying epithelial cells. In chickens, mucin
glycoproteins prevent C. jejuni association with intestinal epithelial cells,
possibly by interfering with their transit through the inner mucus layer
and/or onto the appropriate host cell receptors.
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CONCLUSION AND FUTURE PERSPECTIVES
The visco-elastic mucus gel layer is part of the innate defense
mechanism against infecting bacteria. Mucus colonization by
enteric pathogens inﬂuences the outcome of infection with these
bacteria employing a variety of mechanisms to circumvent the
mucus layer and gain access to underlying epithelial cells. C. jejuni
is attracted to and metabolizes components of mucus. These
bacteria are highly motile with a characteristic spiral shape and
corkscrew-likemotility that suggests an adaptation to the environ-
ment of mucus. Recent studies indicate that mucus and mucins
inﬂuence C. jejuni in a species-speciﬁc manner with chicken
mucins attenuating C. jejuni pathogenicity. Therefore, differences
in the composition of mucus and mucins across species appear
to contribute to C. jejuni disease causing lifestyle in the human
population, as opposed to commensalism in chickens. Increased
knowledge and understanding of the interaction of Campylobacter
with mucus and mucins has the potential to lead to the develop-
ment of intervention strategies that take advantage of the propen-
sity of these bacteria to inhabit the intriguing supramucosal niche
that is the mucus layer.
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